AGITATION,PSYCHOMOTOR
Clinical trials for AGITATION,PSYCHOMOTOR explained in plain language.
Never miss a new study
Get alerted when new AGITATION,PSYCHOMOTOR trials appear
Sign up with your email to follow new studies for AGITATION,PSYCHOMOTOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could cannabis calm Alzheimer's agitation? new trial seeks answers
Symptom relief Recruiting nowThis study tests an oral medication called IGC-AD1, made from a THC compound, to see if it safely reduces agitation in people with mild to severe Alzheimer's dementia. About 164 participants will take the drug or a placebo twice daily for several weeks. The goal is to improve qua…
Matched conditions: AGITATION,PSYCHOMOTOR
Phase: PHASE2 • Sponsor: IGC Pharma, LLC • Aim: Symptom relief
Last updated May 17, 2026 09:34 UTC
-
Shock therapy for dementia agitation: a new hope?
Symptom relief Recruiting nowThis study looks at whether adding electroconvulsive therapy (ECT) to usual care can safely reduce severe agitation in people with moderate to severe dementia, including Alzheimer's and other types. About 50 participants will receive ECT sessions along with their standard treatme…
Matched conditions: AGITATION,PSYCHOMOTOR
Phase: NA • Sponsor: Brent Forester • Aim: Symptom relief
Last updated May 06, 2026 16:13 UTC